Pre-market version of a commercially available hearing instrument with a tinnitus sound generator: feasibility of evaluation in a clinical trial

Int J Audiol. 2017 Apr;56(4):286-294. doi: 10.1080/14992027.2016.1254822. Epub 2016 Nov 25.

Abstract

Objective: This report considers feasibility of conducting a UK trial of combination devices for tinnitus, using data from the study which evaluated different listener programmes available within the pre-market version of Oticon Alta with Tinnitus Sound Generator.

Design: Open and closed questions addressed the following feasibility issues: (1) Participant recruitment; (2) Device acceptability; (3) Programme preferences in different self-nominated listening situations; (4) Usability; (5) Compliance; (6) Adverse events.

Study sample: Eight current combination hearing aid users (all males) aged between 62-72 years (mean age 67.25 years, SD = 3.8).

Results: All eight participants reported the physical aspects and noise options on the experimental device to be acceptable. Programmes with amplification and masking features were equally preferred over the basic amplification-only programme. Individual preferences for the different programme options varied widely, both across participants and across listening situations.

Conclusions: A set of recommendations for future trials were formulated which calls for more "real world" trial design rather than tightly controlling the fitting procedure.

Keywords: Tinnitus; clinical trials; combination device; feasibility; hearing aid; sound therapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acoustic Stimulation / instrumentation*
  • Aged
  • Auditory Perception*
  • Clinical Trials as Topic*
  • Equipment Design
  • Feasibility Studies
  • Hearing Aids*
  • Hearing*
  • Humans
  • Male
  • Middle Aged
  • Noise*
  • Patient Preference
  • Perceptual Masking
  • Research Design
  • Surveys and Questionnaires
  • Tinnitus / diagnosis
  • Tinnitus / physiopathology
  • Tinnitus / psychology
  • Tinnitus / therapy*
  • Treatment Outcome
  • United Kingdom